STONY BROOK, N.Y.–( SERVICE WIRE)– Applied DNA Sciences, Inc. (NASDAQ: APDN) (” Applied DNA” or the “Business”), a leader in Polymerase Domino effect (PCR)- based DNA production, today revealed the growth of industrial activities under its multi-year Master Solutions Contract (MSA) with Nutrition21 where Nutrition21 has actually transitioned to Applied DNA’s CertainT ® platform to protect its IP-protected portfolio of dietary supplement active ingredients. Simultaneously, the Business got 2 follow-on orders for a 2nd year of industrial production, most of which is anticipated to be delivered in the present financial quarter. The monetary regards to the follow-on orders were not divulged.
Nutrition21, a relied on designer and provider of unique and medically validated top quality active ingredients for the dietary supplement market, is the very first to embrace the platform to safeguard the IP of its active ingredients. Using CertainT, Nutrition21 can accredit that its licensees utilize genuine active ingredients and in the appropriate quantities, and likewise recognize IP violation by non-licensees. A SigNature ® molecular tag is used to Nutrition21 active ingredients to offer proof of its item does in ended up items delivered to market. The molecular tag is supported by continuous quality assurance screening services for production and high-resolution screening services for items examined in-market. Nutrition21 holds over 100 domestic and global released and pending patents for its items.
” The growth of CertainT’s application within Nutrition21 is testimony to our platform’s capability to support Nutrition21’s commitment to making sure self-confidence in its active ingredients portfolio,” stated Dr. James A. Hayward, president and CEO, Applied DNA. “With its varied portfolio of trademarked health and health active ingredients, our company believe we remain in the early phases of an impactful industrial relationship with Nutrition21 and, by proxy, the dietary supplements market.”.
Joe Weiss, President of Nutrition21, mentioned, “After a comprehensive search to change our present marker innovation, we have actually now transitioned to the CertainT platform. Marketing partners and consumers of Nutrition21 can feel confident that we will use the CertainT platform to safeguard them versus infringers of our copyright, and most significantly, guarantee customers that they are getting the Nutrition21 active ingredients that are noted on their item label.”.
The CertainT ® platform has 3 innovation pillars (Tag, Test, Track), which enables basic materials and items to be tagged with a special molecular identifier. This identifier can then be checked for its existence as it takes a trip throughout an international supply chain. All the information points associated to tagging and evaluating are tracked by submitting to a safe cloud database. The platform can be utilized throughout markets such as fabrics, marijuana, military, leather, fertilizer, pharmaceuticals, individual care.
About Nutrition21, LLC
Nutrition21 is a relied on designer and provider of unique and medically validated top quality active ingredients for the dietary supplement market. With a varied portfolio of trademarked health and health active ingredients, Nutrition21 supplies component services to a few of the most effective dietary supplement brand names in the market today.
Nutrition21 presently holds over 100 domestic and global released and pending patents for items with extremely valuable claims consisting of: Nitrosigine ®, Velositol ®, Chromax ®, nooLVL ®, and Lepidamax ®. Ingenious Components. Genuine Outcomes
For more details, please go to: www.Nutrition21.com.
About Applied DNA Sciences
Applied DNA is a service provider of molecular innovations that allow supply chain security, anti-counterfeiting and anti-theft innovation, item genotyping, and pre-clinical nucleic acid-based healing drug prospects.
Go to adnas.com to find out more. Follow us on Twitter and LinkedIn. Join our subscriber list.
The Business’s typical stock is noted on NASDAQ under ticker sign ‘APDN’, and its openly traded warrants are noted on OTC under ticker sign ‘APPDW’.
Applied DNA belongs to the Russell Microcap ® Index.
The declarations made by Applied DNA in this news release might be “positive” in nature within the significance of Area 27A of the Securities Act of 1933, Area 21E of the Securities Exchange Act of 1934 and the Personal Securities Lawsuits Reform Act of 1995. Positive declarations explain Applied DNA’s future strategies, forecasts, techniques and expectations, and are based upon presumptions and include a variety of threats and unpredictabilities, much of which are beyond the control of Applied DNA. Real outcomes might vary materially from those forecasted due to, its history of bottom lines, minimal funds, minimal market approval, the unpredictabilities intrinsic in research study and advancement, our capability to effectively participate in industrial agreements for the execution of our CertainT ® platform, disturbances in the supply of basic materials and products, and numerous other aspects detailed from time to time in Applied DNA’s SEC reports and filings, including our Yearly Report on Kind 10-K submitted on December 12, 2019 and our subsequent quarterly reports on Kind 10-Q submitted on February 6, 2020, Might 14, 2020 and August 6, 2020, and other reports we submit with the SEC, which are readily available at www.sec.gov. Applied DNA carries out no responsibility to upgrade openly any positive declarations to show brand-new info, occasions or scenarios after the date hereof or to show the incident of unexpected occasions, unless otherwise needed by law.